Sharps additionally obtained an preliminary qualification buy order for DisGard™ single-use Sharps Restoration System
Firm transitions to income producing with second buy order, bringing complete current orders to roughly $500,000 for the quarter
NEW YORK, Could 06, 2025 (GLOBE NEWSWIRE) — Sharps Know-how, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an progressive medical machine and pharmaceutical packaging firm providing patented, best-in-class smart-safety syringe merchandise to the healthcare trade, broadcasts the receipt of a $100,000 buy order from a Hungarian vaccine supplier. This order helps the not too long ago introduced $400,000 SoloGard™ order, which is a part of a broader $50 million settlement that was beforehand introduced with a U.S. firm and represents the primary SecureGard™ order from this Hungary-based firm.
“I’m happy to announce our second vital buy order thus far, bringing our complete orders obtained for Q2 to roughly $500,000,” said Robert Hayes, Chief Govt Officer of Sharps Know-how. “These newest orders mark the primary for our SecureGard and Disgard™ product traces, and we’re excited to start what we anticipate might be a long-term relationship with these prospects. With this milestone, Sharps has formally transitioned right into a commercial-stage firm, which is a pivotal second in our progress trajectory.”
Along with the current order for SecureGard, Sharps additionally obtained an preliminary qualification order for the DisGard Sharps Restoration System – a compact, single-use surgical sharps container designed to assist secure, point-of-use disposal in working rooms and outpatient procedures. The system performs an important function in surgical stock restoration by securing small sharps instantly after use, serving to healthcare suppliers scale back lack of surgical devices and mitigate harm dangers.
Mr. Hayes concluded: “SecureGard, SoloGard, and DisGard are all manufactured at our state-of-the-art facility in Hungary, the place we at present preserve stock ranges to satisfy ongoing and future demand. We’re well-positioned to execute on our increasing pipeline of buy agreements and stay centered on scaling manufacturing and success. We stay up for holding our shareholders knowledgeable as we proceed constructing momentum and delivering on our strategic imaginative and prescient.”
About SecureGard® Retractable Security Syringe:
The SecureGard Retractable Security Syringe is a single-use, sterile, disposable hypodermic syringe with a needle hooked up which is meant for allotting/administering fluids in medical apply. The important thing security characteristic, the place the clinician retracts the hypodermic needle by manually locking the plunger onto the needle hub, withdrawing the plunger, pulling the needle into the barrel and breaking the plunger, nearly eliminates the unintentional medical reuse of the syringe and unintentional needle stick accidents.
Benefits of SecureGard Retractable Needles:
- Low lifeless area (LDS) – scale back drug wastage
- No change in method, requires minimal coaching
- Handbook retraction
- Low-cost resolution
- Latex free
- Breakaway plunger
- Obtainable in 1ml, 3ml and 5ml capability
- Watch a video on SecureGard: HERE
- Go to the SecureGard web site: HERE
About Sharps Know-how:
Sharps Know-how is an progressive medical machine and pharmaceutical packaging firm providing patented, best-in-class smart-safety syringe merchandise to the healthcare trade. The Firm’s product traces give attention to offering ultra-low waste capabilities, that incorporate syringe applied sciences that use each passive and lively security options. Sharps additionally affords merchandise which can be designed with specialised copolymer know-how to assist the prefillable syringe market phase. The Firm has a producing facility in Hungary. For extra data, please go to www.sharpstechnology.com.
FORWARD-LOOKING STATEMENTS:
This press launch incorporates “forward-looking statements”. Ahead-looking statements mirror our present view about future occasions. When used on this press launch, the phrases “anticipate,” “consider,” “estimate,” “anticipate,” “future,” “intend,” “plan,” “poised” or the adverse of those phrases and related expressions, as they relate to us or our administration, determine forward-looking statements. Such statements, embrace, however usually are not restricted to, statements contained on this press launch regarding our enterprise technique, our future working outcomes and liquidity, and capital sources outlook. Ahead-looking statements are based mostly on our present expectations and assumptions concerning our enterprise, the financial system, and different future situations. As a result of forward-looking statements relate to the longer term, they’re topic to inherent uncertainties, dangers, and modifications in circumstances which can be troublesome to foretell. Our precise outcomes could differ materially from these contemplated by the forward-looking statements. They’re neither statements of historic truth nor ensures of assurance of future efficiency. We warning you due to this fact towards counting on any of those forward-looking statements. Vital components that might trigger precise outcomes to vary materially from these within the forward-looking statements embrace, with out limitation, our means to boost capital to fund persevering with operations; our means to guard our mental property rights; the affect of any infringement actions or different litigation introduced towards us; competitors from different suppliers and merchandise; our means to develop and commercialize services and products; modifications in authorities regulation; our means to finish capital elevating transactions; and different components regarding our trade, our operations and outcomes of operations. Precise outcomes could differ considerably from these anticipated, believed, estimated, anticipated, meant, or deliberate. Components or occasions that might trigger our precise outcomes to vary could emerge once in a while, and it’s not potential for us to foretell all of them. We can not assure future outcomes, ranges of exercise, efficiency, or achievements. The Firm assumes no obligation to replace any forward-looking statements as a way to mirror any occasion or circumstance that will come up after the date of this launch.
Investor Contact:
Holdsworth Companions
Adam Holdsworth
Cellphone: 917-497-9287
E-mail: IR@sharpstechnology.com
